Clinical Outcome Of Advanced Renal Cell Carcinoma In Taiwan

NCT02776644 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1349

Last updated 2023-03-16

Study results available
· View outcomes & findings →

Summary

The clinical outcome of advanced / metastatic renal cell carcinoma has been changed since targeted therapy being widely applied. This study will retrospectively analyse the clinical outcome of advanced renal cell carcinoma captured in Taiwan National Health Insurance Research Database.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-15
Primary Completion
2017-12-30
Completion
2017-12-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02776644 on ClinicalTrials.gov